National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

recombinant interleukin-1-beta
A recombinant therapeutic agent which is chemically identical to or similar to the endogenous protein cytokine interleukin 1 (IL-1)-beta. Produced by monocytes and activated macrophages, endogenous mature IL-1 is generated through proteolytic cleavage by proteases such as IL-1-beta converting enzyme (ICE). This agent promotes angiogenesis, fibroblast proliferation, and neutrophil chemotaxis; it also regulates the functions of lymphocytes and epithelial cells and is involved in the 'acute phase response' to infection. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:interleukin-1-beta
Abbreviation:IL-1-b



Previous:recombinant interferon alpha-1b, recombinant interferon alpha-2a, recombinant interferon beta, recombinant interferon gamma, recombinant interleukin-1-alpha
Next:recombinant interleukin-11, recombinant interleukin-12, recombinant interleukin-18, recombinant interleukin-3, recombinant interleukin-4

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov